Daily Archives: October 12, 2022
RCT | No difference in cardiovascular outcomes with evening vs. morning dosing of usual antihypertensives.
12 Oct, 2022 | 14:01h | UTCRelated Consensus Statement: Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension – Journal of Hypertension
Related study (conflicting results): Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction in Randomized Trial
USPSTF Statement | Screening for anxiety is recommended in children and adolescents aged 8 to 18 years.
12 Oct, 2022 | 13:58h | UTCEditorial: Screening for Pediatric Anxiety Disorders – JAMA
Evidence Report: Screening for Anxiety in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
JAMA Patient Page: Screening for Anxiety in Children and Adolescents
Author interview: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents – JAMA
USPSTF Statement | Screening for depression and suicide risk is recommended in children and adolescents aged 12 to 18 years.
12 Oct, 2022 | 14:00h | UTCEditorial: Screening for Adolescent Depression and Suicide Risk – JAMA
JAMA Patient Page: Screening for Depression and Suicide Risk in Children and Adolescents
Author Interview: USPSTF Recommendations: Screening for Anxiety in Children and Adolescents, and Depression and Suicide Risk Screening in Children and Adolescents – JAMA
Perioperative cardiovascular assessment guideline: focus on managing patients with percutaneous coronary intervention.
12 Oct, 2022 | 13:56h | UTC
Guideline | Evaluation and management of venous thromboembolism.
12 Oct, 2022 | 13:55h | UTCJoint Guideline on Venous Thromboembolism – 2022 – Arquivos Brasileiros de Cardiologia
Guideline | Evaluation and management of myocarditis.
12 Oct, 2022 | 13:56h | UTC
Consensus Recommendations | Minimizing the risk of monkeypox virus transmission during fecal microbiota transplantation.
12 Oct, 2022 | 13:54h | UTC
Benefits and risks associated with continuation of anti–TNF after 24 weeks of pregnancy in inflammatory bowel disease.
12 Oct, 2022 | 13:52h | UTCBenefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary: Continuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial – HealthDay
Commentary on Twitter
10 year trial found continuation of #AntiTNF treatment after 24 weeks of pregnancy appears beneficial for #IBD activity and prematurity, not affecting neonatal outcomes and serious infections in the offspring. @EPIPHARE https://t.co/YuytSQqDsE pic.twitter.com/CRGN80K93A
— Annals of Int Med (@AnnalsofIM) September 27, 2022
Systematic Review | Splinting for the non‐operative management of developmental dysplasia of the hip in children under six months.
12 Oct, 2022 | 13:53h | UTC
Brief Review | Frailty in intensive care medicine must be measured, interpreted and taken into account!
12 Oct, 2022 | 13:51h | UTC
Commentary on Twitter
Frailty should be evaluated in old #ICU pts to improve individual care & resource allocation! To-do list
? measure or estimate; use easy, validated/proven tools & be consistent
? interpret
⚖️ take into account (w other data) to support decision making
? https://t.co/J4qropYqon pic.twitter.com/NiBifBwmIm— Intensive Care Medicine (@yourICM) October 7, 2022